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A Chronic myeloid leukaemia (CML) case with a new complex t(9;18;22)(q34;p11;q11) of a 29-year-old man is being reported.
For the ﬁrst time, this translocation has been characterized by karyotype complemented with ﬂuorescence in situ hybridization
(FISH). In CML, the complex and standard translocations have the same prognosis. The patient was treated with standard initial
therapy based on hydroxyurea before he died due to heart failure four months later. Our ﬁnding indicates the importance of
combined cytogenetic analysis for diagnosis and guidance of treatment in clinical diagnosis of CML.
Copyright © 2007 A. El Andaloussi and C. Bilhou-Nabera. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
Chronic myeloid leukaemia (CML) is a myeloproliferative
disorder characterized in about 95% of cases by the presence
of the Philadelphia (Ph) chromosome (t(9;22)(q34;q11))[1].
It is a result from a reciprocal translocation between the
long arms of chromosomes 9 and 22 [2]. About 3-4% of
Ph-positive patients with CML have variant translocations
[3, 4], involving another chromosome [5]. These variant
translocation have been classiﬁed as “simple” and as “com-
plex” when chromosomes 9, 22, and at least one other
chromosome are involved [6]. Both translocations have the
same prognosis. Here, we present the ﬁrst report of a com-
plex variant Ph translocation involving chromosome 18:
t(9;18;22)(q34;p11;q11).
2. MATERIALS AND METHODS
2.1. Casereport
InJuly2000,a29-year-oldmanwasadmittedforfatiguewith
anaemic syndrome to the Averroes Hospital (Casablanca,
Morocco). For this patient, the diagnosis of CML has been
retained in front of the existence of a spleenomegalia and in
view of the following blood formula: Hb 8.7g/dl; platelets
566×109 /L;andwhitebloodcells189×109 /Lwith34%neu-
trophils and 31% myelocytes. Morphologic examination of
the bone marrow biopsy was consistent with CML in chronic
phase. Treatment with hydroxyurea initially (5cp/day) re-
sulted in a clinical response, with normalization of the pe-
ripheral blood values. In May 2001, his WBC was 21800/µl,
with Hb of 12.5g/dl; the diﬀerential leukocytes count was
13% myelocytes and 5% metamyelocytes. At diagnosis, the
cytogenetic analysis on bone marrow metaphases revealed a
complex karyotype with der(18). Four months later the pa-
tients died due to a heart failure.
2.2. Cytogeneticanalysis
Unstimulated bone marrow cells obtained at the time of pri-
mary diagnosis were cultured for 24 hours in RPMI 1640
medium supplemented with 20% fetal calf serum, 1% L-
glutamine, 1% antibiotics, and without mitogens. After in-
cubation,thecellswereexposedtoColcemid(0.01µg/ml)for
30 minutes, followed by hypotonic treatment (0.075MKCl),
and were ﬁxed with methanol-glacial acetic acid solution2 Journal of Biomedicine and Biotechnology
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Figure 1: Karyotype from a bone marrow metaphase of the patient
showing 46,XY,t(18;22)(p11;q11). The arrows indicate the impli-
cated chromosomes.
(3 : 1). Chromosomes were spread on cold, wet slides, dried,
and banded with the RHG technique. Karyotype was inter-
preted according to International System for Human Cyto-
genetic Nomenclature (ISCN 2005) recommendation [7]. A
minimum of 20 metaphases were analyzed and no signs of
clone were found in the samples.
2.3. FISHanalysis
Fluorescence in situ hybridization (FISH) was performed on
methanol-acetic acid ﬁxed bone marrow cells [8]. Commer-
cially available, diﬀerentially labelled probes (LSI bcr/abl ex-
trasignal (ES) dual color; Vysis) were used to detect the re-
arranged BCR/ABL gene. In addition, biotin-labelled whole
chromosome painting probes (WCPs) (Cambio, UK) were
used to detect abnormal chromosome 18 and 22. The hy-
bridisationprotocolfollowedthemanufacturer’srecommen-
dations. Fluorescent signals were captured with a cooled
charge-coupled device (CCD) camera attached to a micro-
scope with triple-band ﬁlters (Olympus Optical Co., Tokyo,
Japan) and processed using an image analysis system.
3. RESULTS
Twenty metaphases were analyzed at diagnosis and R-
banding showed the following karyotype: 46,XY,t(18;
22)(p11;q11). Both chromosomes 9 looked unsuspicious
(see Figure 1). The RT-PCR analysis revealed the BCR/ABL
fusion with b3a2 junction, which indicated the breakpoint
within the major breakpoint cluster region of the BCR gene
(M-BCR)(data not shown). Conventional cytogenetic re-
sults were reﬁned by FISH analysis. Dual Color FISH (DC-
FISH) analysis of interphase nuclei and metaphase using
LSI BCR/ABL extrasignal (ES) translocation probe showing
the yellow (red-green) fusion on the der(22), a BCR sig-
nal (green) was observed on the normal 22, an ABL sig-
der(22)/Ph
9
der(9)
(a)
der(9)
22
der(18)
18
(b)
Figure 2: FISH analysis demonstrating the presence of t(9;18;
22)(q34;p11;q11). (a) Using the bcr/abl (ES) probe, we observed a
red signal on the normal chromosome 9, a smaller red signal re-
tained on the der(9), a green signal on the normal chromosome
der(22), and a yellow fusion signal on the der(22). Using 4,6-
diamidino-2-phenylindol (DAPI) counterstain, a G-banding-like
pattern of the same metaphase can be obtained. (b) Fluorescence
in situ hybridization with the use of whole chromosome painting
probes der(18).
nal (red) on the normal 9, a smaller ABL signal retained on
the other chromosome 9 (see Figure 2(a)). Further investiga-
tion, using a combination of the library probe for chromo-
some9andthelibraryprobeforchromosome22showedone
chromosome 9 painted red, and the other homologue with
part of the long arm painted green indicating a rearrange-
ment (see Figure 2(b)). The karyotype was thus redeﬁnedA. El Andaloussi and C. Bilhou-Nabera 3
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Figure 3: The two-step t(9;18;22) translocation diagram. The ﬁrst
event is classic translocation t(9;22). The second event is transloca-
tion between der(22) and chromosome 18p11 and between der(18)
and der(9).
to t(9;22;18)(q34;q11;p11). Fluorescence in situ hybridiza-
tion with the use of whole chromosome painting probes 18
showed one normal chromosome 18, one shorter, apparently
fully painted chromosome 18, and material from chromo-
some 18 on the distal part on the long derivative 9q+ (see
Figures 2(b) and 3).
4. DISCUSSION
The complex abnormalities in CML remain intriguing be-
cause of the wide range of chromosomal involvement with
no apparent clinical eﬀect [9, 10]. Variant type Ph translo-
cations have been described using cytogenetic analysis [4]
and molecular techniques. Whether these translocations re-
sult from sequential events or from a “concerted genomic
rearrangement” with a simultaneous break of the chromo-
somal regions involved followed by a mismatched joining
of the broken ends in a one-step mechanism remain to be
determined [11]. The genesis of variant translocations via
two-step mechanisms is also possible [12]. The application
of FISH and RT-PCR allowed us to reﬁne the cytogenetic
data [13]. Recently, it was shown signiﬁcant positive cor-
relation between breakpoint location and CG composition
[14]. In this study, we have demonstrated the existence of a
BCR/ABL chimeric transcript, giving rise to a b3a2 mRNA
transcript, and we showed that material from chromosome 9
wastranslocatedtochromosome22,aswellasfromchromo-
some 22 to chromosome 18. The variant Ph translocations
involving chromosome 18 seem very uncommon because
any case of t(18;22)(p11;q11) has been previously described.
These results suggest that combinatorial probe hybridization
is very useful for deﬁning both the standard translocation,
t(9;22), and the variant form of Ph translocations. The com-
parison of conventional cytogenetic and FISH analysis re-
sults, suggests that FISH is a more sensitive method to detect
and to explain the variant translocations in CML.
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